Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...
Katherine Legge ready for first race on Daytona's historic oval TOP PICK FOR YOU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback